Manaʻo ʻo ʻAmelika i kahi "Hoʻomaha" ma ka Johnson & Johnson COVID-19 Vaccine ma muli o nā hopohopo koko.

Anter

• Nānā no

Ke noi aku nei nā Centres for Disease Control and Prevent (CDC) a me Food and Drug Administration (FDA) e "hoʻomaha" ka lawelawe ʻana o ka lāʻau vaccine Johnson & Johnson COVID-19 me ka hāʻawi ʻia ʻana o 6.8 miliona mau kaha ma US no kēia lā. Hele mai ka nūhou ma o kahi ʻōlelo hui e hōʻike ana i nā lawelawe mālama ola e hoʻopau i ka hoʻohana ʻana o ka lāʻau lapaʻau ʻo Johnson & Johnson a hiki i ka wā e hoʻolaha hou ai. (E pili ana: ʻO nā mea āpau e pono ai ʻoe e ʻike e pili ana i ka maʻi maʻi COVID-19 a Johnson & Johnson)

ʻO kēia ʻōlelo aʻoaʻo ka hopena o kahi ʻano kakaikahi akā koʻikoʻi o ke kīpē koko i kapa ʻia he cerebral venous sinus thrombosis (CVST) i loaʻa i kekahi mau kānaka i loaʻa ka lāʻau lapaʻau kūikawā ma ka U.S., e like me ka ʻōlelo. I kēia hihia, ʻo ka "rare" ʻo ia hoʻi he ʻeono wale nō mau hihia i hōʻike ʻia o ke koko ma hope o ka hoʻopaʻa ʻana i ke koko mai loko mai o kēlā mau ʻāpana kokoke i 7 miliona. I kēlā me kēia hihia, ʻike ʻia ke kīʻaha koko i ka hui pū ʻia me ka thrombositopenia, aka nā haʻahaʻa haʻahaʻa o nā platelet koko (nā ʻāpana o ke kelepona i kou koko e ʻae ai i kou kino e hana i nā clots e kū a pale i ke kahe ʻana o ke kahe. I kēia manawa, ʻo nā hihia i hōʻike ʻia o CVST a me thrombocytopenia ma hope o ka maʻi maʻi Johnson & Johnson i nā wahine ma waena o nā makahiki 18 a me 48, 6 a 13 mau lā ma hope o ka loaʻa ʻana o ka lāʻau lapaʻau hoʻokahi, e like me ka FDA a me CDC.

ʻO CVST kahi ʻano hahau laha ʻole, e like me ka Johns Hopkins Medicine. (ICYDK, kahakaha nui e wehewehe ai i kahi hanana i "ke keʻakeʻa ʻia a hoʻemi ʻia paha ke koko i kekahi ʻāpana o kou lolo, e pale ana i nā kiko o ka lolo mai ka loaʻa ʻana o ka oxygen a me nā meaola," e like me ka Mayo Clinic. ka lolo o ka venous sinuses (nā ʻeke ma waena o nā papa o waho o ka lolo), ka mea e pale ai i ke kahe ʻana o ke koko mai ka lolo. Ke hiki ʻole i ke koko ke hoʻoheheʻe, hiki i kahi hemorrhage ke hana, ʻo ia hoʻi ka hiki i ke koko ke hoʻomaka e kahe i loko o nā lolo o ka lolo. ʻO nā hōʻailona o ka CVST e pili ana i ka maʻi poʻo, ka ʻike makapō, ka maule a i ʻole ka nalo ʻana o ka ʻike, ka nalowale o ka mana o ka neʻe ʻana, ka hopu ʻana, a me ka coma, e like me ka John Hopkins Medicine. (Pili: Pehea ka maikaʻi o ka Vaccine COVID-19?)

Hāʻawi ʻia i ka helu haʻahaʻa o nā hōʻike CVST mai nā poʻe āpau i loaʻa i ka lāʻau lapaʻau ʻo Johnson & Johnson COVID-19, e noʻonoʻo paha ʻoe inā he overreaction ka pane a CDC a me FDA. ʻO ka ʻoiaʻiʻo o ka hui pū ʻana o ke koko a me nā platelets haʻahaʻa, ʻo ia ka mea i ʻike nui ʻia kēia mau hihia, wahi a Peter Marks, M.D., Ph.D., ka luna o ka FDA Center for Biologics Evaluation and Research, i loko o kahi hōʻike hoʻolaha. "ʻO kā lākou hanana pū kekahi e hana i kahi hiʻohiʻona a ʻano like loa kēlā ʻano me ka mea i ʻike ʻia ma ʻEulopa me kahi lāʻau lapaʻau ʻē aʻe," i ʻōlelo ʻo ia. Maliʻa paha e ʻōlelo ana ʻo Kauka Marks i ka lāʻau lapaʻau AstraZeneca, i ka nūhou e hoʻopōkole ana nā ʻāina he nui ma ʻEulopa i kā lākou hoʻohana ʻana i ka lāʻau i ka mahina i hala ma muli o nā hōʻike e pili ana i ke kō ʻana o ke koko a me nā platelet haʻahaʻa.

ʻO ka maʻamau, hoʻohana ʻia kahi lāʻau coagulant i kapa ʻia heparin e mālama i nā clots koko, e like me ka ʻōlelo a ka CDC a me FDA. Akā hiki i ka heparin ke hāʻule i nā pae platelet, no laila hiki ke weliweli ke hoʻohana ʻia i nā poʻe i loaʻa ka helu platelet haʻahaʻa, e like me ka hihia o nā wahine ʻeono me nā pilikia J & J. ʻO ka hoʻomaha ʻana i ka hoʻohana ʻana i ka lāʻau lapaʻau he hoʻāʻo ia e "hōʻoia i ka poʻe hoʻolako e ʻike inā ʻike lākou i ka poʻe me nā platelets koko haʻahaʻa, a inā ʻike lākou i ka poʻe he koko koko, pono lākou e nīnau e pili ana i ka mōʻaukala o ka lāʻau lapaʻau hou a laila hana. e like me ka wehewehe ʻana a me ka hoʻokele ʻana o kēlā mau kānaka, "i wehewehe ʻia e Dr. Marks i ka wā o ka ʻōlelo haʻi ʻōlelo.

He mea nui ia e hoʻomaopopo i ka manaʻo o ka CDC a me FDA i ka "hoʻomaha" ʻaʻole ia he manaʻo e hoʻopau loa ʻia ka lawelawe ʻana o ka maʻi maʻi Johnson & Johnson. "Ke paipai aku nei mākou e hoʻomaha ʻia ka lāʻau lapaʻau ma ke ʻano o ka hoʻoponopono ʻana," wahi a Dr. Marks i ka wā o ka haʻi ʻōlelo. "Eia nō naʻe, inā he kamaʻilio ka mea mālama ola pilikino me kahi mea hoʻomanawanui a hoʻoholo lākou he kūpono ka pōmaikaʻi / pilikia no kēlā mea hoʻomanawanui, ʻaʻole mākou e hōʻoki i kēlā mea lawelawe mai ka lawelawe ʻana i ka lāʻau lapaʻau." E ʻoi aku ka nui o nā pōmaikaʻi ma mua o nā pilikia i "ka hapa nui o nā hihia," i hoʻohui ʻo ia.

Inā ʻo ʻoe kekahi o nā miliona o ka poʻe ʻAmelika i loaʻa i ka lāʻau i kā Johnson a me Johnson, mai makaʻu. "No ka poʻe i loaʻa i ke kano ma mua o hoʻokahi mahina i hala aku nei, ua haʻahaʻa loa ka hanana pilikia i kēia manawa," wahi a Anne Schuchat, M.D., ka luna nui o ka CDC, i ka wā o ka puʻupuʻu media. "No ka poʻe i loaʻa ka lāʻau lapaʻau i loko o nā pule i hala iho nei, pono lākou e makaʻala e nānā no nā hōʻailona. Inā loaʻa iā ʻoe ka lāʻau lapaʻau a hoʻomohala i nā poʻo ʻeha, ʻeha o ka ʻōpū, ʻeha o ka wāwae, a me ka liʻiliʻi o ka hanu, pono ʻoe e hoʻopili aku i kāu mea mālama ola kino a e ʻimi i ka lāʻau lapaʻau." (Pili: Hiki iā ʻoe ke hana ma hope o ka loaʻa ʻana o ka Vaccine COVID-19?)

Pololei ka ʻike ma kēia moʻolelo e like me ka manawa paʻi. Eia nō naʻe, ke hoʻomau nei ka ulu ʻana o ke kūlana e pili ana iā COVID-19, ua loli paha kekahi mau ʻike mai ka wā i paʻi ʻia ai. ʻOiai ke hoʻāʻo nei ʻo Health e mālama i kā mākou mau moʻolelo e like me ka hiki, ke paipai pū nei mākou i ka poʻe heluhelu e hoʻomau i ka ʻike i nā nūhou a me nā ʻōlelo aʻoaʻo no ko lākou mau kaiaulu ponoʻī ma o ka hoʻohana ʻana i ka CDC, WHO, a me kā lākou ʻoihana olakino lehulehu ma ke ʻano he kumu waiwai.

Nānā no